Paul Edattel is named as a lobbyist on federal disclosure filings for 76 clients through Todd Strategy Group. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Pharmacy and Copyright/Patent/Trademark.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| PERSONALIS, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Pharmacy |
| MRO CORPORATION | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| INOVIO PHARMACEUTICALS | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| GUARDANT HEALTH, INC. | TODD STRATEGY GROUP | Q2 2026 | Health Issues |
| MCKESSON CORPORATION | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid |
| U.S. CHAMBER OF COMMERCE GLOBAL INNOVATION POLICY CENTER | TODD STRATEGY GROUP | Q3 2026 | Copyright/Patent/Trademark |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| MENARINI GROUP | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid |
| EXELIXIS, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark |
| ELI LILLY AND COMPANY | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| ASTELLAS PHARMA US, INC. | TODD STRATEGY GROUP | Q3 2026 | Copyright/Patent/Trademark, Pharmacy, Health Issues |
| AMERICAN MEDICAL ASSOCIATION | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| PUERTO RICO DEPARTMENT OF HEALTH | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Budget/Appropriations |
| MYRIAD GENETICS, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid |
| GLAXOSMITHKLINE LLC | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| GENMAB | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| FOX CORPORATION | TODD STRATEGY GROUP | Q3 2026 | Telecommunications, Communications/Broadcasting/Radio/TV, Taxation/Internal Revenue Code |
| CAREDX, INC. | TODD STRATEGY GROUP | Q2 2026 | Medicare/Medicaid |
| NOVO NORDISK INC. | TODD STRATEGY GROUP | Q3 2026 | Pharmacy, Health Issues |
| DELFI DIAGNOSTICS | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Pharmacy, Health Issues |
| SOUTHWEST TRANSPLANT ALLIANCE | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| COMPASS PATHWAYS INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| AMERICAN SOCIETY OF NEPHROLOGY | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| ALKERMES, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| ASTRAZENECA PHARMACEUTICALS LP | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Tariff (miscellaneous tariff bills) |
| AMGEN INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| PFIZER INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Pharmacy |
| MILLIPORESIGMA | TODD STRATEGY GROUP | Q3 2026 | Pharmacy |
| ILLUMINA, INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| GILEAD SCIENCES, INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| BRISTOL-MYERS SQUIBB COMPANY | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| BIOGEN, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| VAXART INC. | TODD STRATEGY GROUP | Q3 2026 | Medical/Disease Research/Clinical Labs |
| VANTIVE US HEALTHCARE LLC | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| VALISURE | TODD STRATEGY GROUP | Q3 2026 | Pharmacy |
| THE COALITION FOR 21ST CENTURY MEDICINE | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| SIDECAR HEALTH | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Medicare/Medicaid |
| NOVARTIS, INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| NOMI HEALTH, INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| NCTA - THE INTERNET & TELEVISION ASSOCIATION | TODD STRATEGY GROUP | Q3 2026 | Telecommunications |
| MUTUAL OF OMAHA | TODD STRATEGY GROUP | Q3 2026 | Insurance |
| MEDICAL COUNTERMEASURES COALITION | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| JOHNSON & JOHNSON SERVICES, INC. | TODD STRATEGY GROUP | Q3 2026 | Veterans, Health Issues |
| CALYXO, INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| BIODESIX, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| BAYER CORPORATION | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Taxation/Internal Revenue Code, Medicare/Medicaid |
| AMERICAN COLLEGE OF RADIOLOGY | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid |
| EMD SERONO INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Pharmacy, Health Issues |
| PMI US CORPORATE SERVICES INC. | TODD STRATEGY GROUP | Q3 2026 | Tobacco, Government Issues, Budget/Appropriations |
| PERIMETER SYSTEMS, INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| MERCK & CO., INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| GENENTECH, INC. | TODD STRATEGY GROUP | Q3 2026 | Budget/Appropriations, Medicare/Medicaid, Health Issues |
| APOLLO GLOBAL MANAGEMENT | TODD STRATEGY GROUP | Q3 2026 | Financial Institutions/Investments/Securities |
| ALNYLAM PHARMACEUTICALS, INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Pharmacy |
| DH DIAGNOSTICS LLC | TODD STRATEGY GROUP | Q1 2026 | Health Issues |
| WINE & SPIRITS WHOLESALERS OF AMERICA | TODD STRATEGY GROUP | Q1 2026 | Taxation/Internal Revenue Code |
| SIEMENS HEALTHINEERS | TODD STRATEGY GROUP | Q1 2026 | Medicare/Medicaid |
| THE ORTHOFORUM | TODD STRATEGY GROUP | Q2 2026 | Medicare/Medicaid |
Showing the 60 most recent of 76 engagements.
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 64 | 1 |
| 2025 | 71 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 32 | $98K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Paul Edattel. See the Capitol Clarity rankings and method.